Please try another search
GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, disease mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breeding, animal quality testing, and other services. The company was founded in 2017 and is headquartered in Nanjing, China.
Name | Age | Since | Title |
---|---|---|---|
Bo Yu | 53 | 2020 | Independent Director |
Bin-Qing Xiao | 44 | 2020 | Independent Director |
Tao Wen | 44 | 2020 | Supervisor |
Jing Zhao | 43 | 2018 | CEO, GM, Secretary & Director |
Xiang Gao | 61 | 2017 | Chairman of the Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review